CERE Cerevel Corp: Nilai pasar

Logo perusahaan publik Cerevel Therapeutics, Inc. (CERE)

This price chart for Cerevel Therapeutics (CERE) on the GURU.Markets platform reflects a sovereign development cycle, rendering the asset a defensive asset due to stable demand for healthcare. The business focuses on developing therapies to combat Parkinson's disease and schizophrenia, targeting the massive CNS market. However, geopolitical tensions and sanctions complicate component logistics, which slows down drug registration, and the metric stands at 8.21.

Cerevel Therapeutics, Inc. - Nilai pasar CERE (periode 04.07.2022 - 10.08.2024)

CERE (Cerevel Corp): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Cerevel Therapeutics (CERE):
Rega saham Cerevel Therapeutics, Inc.|CERE - Rata-rata rega prakiraan|Nilai pasar Cerevel Corp
Analisis fundamental perusahaan:CERE (Cerevel Therapeutics, Inc.)
Sampel barang cerevel.com

Cerevel Therapeutics specializes in developing innovative therapies for central nervous system diseases. The dynamics of the issuer's market capitalization reflect the market's valuation of the success of these clinical developments. This figure is calculated as the product of the current share price and the total number of outstanding securities. This metric determines the total value of the equity capital and the financial weight of the enterprise. Analyzing this indicator allows for an assessment of the company's investment attractiveness within the biotechnology sector.

Pesaing wigati

Kapitalisasi pasar BIIB (Biogen)|Neurocrine (NBIX) - Nilai pasar|RGC - Nilai pasar|Nilai pasar AXSM (Axsome Corp)|ACAD: Kapitalisasi pasar|Nilai pasar xenon-pharma.com (XENE)|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Biji pasar Prothena Corp (PRTA)|Kapitalisasi pasar ALEC|ANNX - Nilai pasar|Nilai pasar Omeros OMER|Nilai pasar NGNE|AC Immune - Kapitalisasi pasar|Nilai pasar voyagertherapeutics.com|NMRA (Neumora Therapeutics, Inc.) - Biji pasar|SCLX (Scilex Holding) - Nilai pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Nilai pasar Alpha Cognition Corp ACOG|Nilai pasar Cognition Therapeutics, Inc. (CGTX)|Nilai pasar IKT (inhibikase.com)|Cassava Sciences - Biji pasar|Nilai pasar ASRT|COYA: Biji pasar|Vistagen Therapeutics - Nilai pasar|OVID: Kapitalisasi pasar|acumenpharm.com - Nilai pasar|CRVO (CervoMed) - Kapitalisasi pasar|Nilai pasar Alterity Therapeutics Ltd ATHE|Nilai pasar Clene Inc. (CLNN)|PEPG (pepgen.com) - Nilai pasar|Kapitalisasi pasar JUNS (Jupiter Neurosciences)|Kapitalisasi pasar relmada.com RLMD|ANVS - Nilai pasar|Biji pasar GRCE|AIFF: Kapitalisasi pasar|Nilai pasar Klotho Neurosciences (KLTO)|Biji pasar NRSN|Kapitalisasi pasar revivapharma.com|Biji pasar MTVA (MetaVia Inc)|Nilai pasar NRXS|Kapitalisasi pasar HSDT (Helius Medical Technologies)|Kapitalisasi pasar Passage Bio Inc. (PASG)|Neuphoria - Kapitalisasi pasar|minervaneurosciences.com (NERV) - Biji pasar|Athira Pharma (ATHA) - Nilai pasar|ADXN - Kapitalisasi pasar|ALZN (Alzamend Neuro Inc.) - Kapitalisasi pasar|Biji pasar Cyclerion (CYCN)|Kapitalisasi pasar PTIX|KTTA - Nilai pasar|Nilai pasar Cortigent CRGT|Nilai pasar ATXI|Brainstorm Cell Therapeutics, Inc. - Kapitalisasi pasar|Nilai pasar Cara Therapeutics Inc|Chromocell Therapeutics (CHRO) - Nilai pasar|Kapitalisasi pasar ELYM|ITCI (Intra-Cellular Therapies Inc.) - Kapitalisasi pasar|Nilai pasar Longboard Pharmaceuticals Inc LBPH|Biji pasar MRNS (Marinus)|Kapitalisasi pasar NKGen Biotech Corp (NKGN)|Nilai pasar NeuroBo Pharmaceuticals NRBO|Nilai pasar SAGE|SNPX - Nilai pasar|Nilai pasar Trevena Inc.|VIGL: Kapitalisasi pasar|Biji pasar anewmeds.com